Rates by country

DAMC01
 
Consumption of Antibacterials for systemic use (ATC group J01) in the community (primary care sector) in Europe, reporting year 2015
Consumption of Antibacterials for systemic use (ATC group J01) in the community (primary care sector) in Europe, reporting year 2015
Country
DDD per 1000 inhabitants and per day
Austria
14.0
Belgium
29.3
Bulgaria
21.4
Croatia
21.8
Cyprus*
31.1
Czech Republic
19.5
Denmark
16.1
Estonia
11.6
Finland
17.2
France
29.9
Germany
14.4
Greece
36.1
Hungary
17.0
Iceland
19.9
Ireland
25.6
Italy
27.5
Latvia
13.3
Liechtenstein
-
Lithuania
16.7
Luxembourg
26.3
Malta
22.2
Netherlands
10.7
Norway
15.8
Poland
26.2
Portugal
21.3
Romania*
33.3
Slovakia
24.5
Slovenia
14.5
Spain
22.2
Sweden
0.0
United Kingdom
20.1
* Country provided only total care data.
* Country provided only total care data.
References:
1. Sub-classification of macrolides:
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45.
2. Sub-classification of quinolones
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi47-56.
3. Classification of antivirals for systemic use based on their main indication
Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, et al. European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother. 2011 Aug;66(8):1897-905.
General comments for comparison of antimicrobial consumption data from different countries and/or years:
Total care includes data both from the hospital sector and community (primary care sector) and overestimates the figures when used for reporting for the community sector.
Some countries report reimbursement data that do not include consumption of antimicrobials obtained without prescription and other non-reimbursed courses.
For more information please see the report "Data source overview of antimicrobial consumption"
Finland: hospital sector data include consumption in remote primary health care centres and nursing homes, thus overestimating hospital consumption and underestimating community consumption compared to the other countries that report data from these sources as community consumption.
This report has been generated from ESAC-Net data submitted to TESSy, The European Surveillance System on 2017-10-19. The report reflects the state of submissions in TESSy as of 2017-10-19 at 11:01
Page last updated 10 Jul 2017